Lipoprotein lipase plays a major role in the regulation of lipid metabolism. The enzyme acts to hydrolyse triglycerides, providing free fatty acids for energy generation or storage, thus affecting the maturation of circulating lipoproteins. Biochemical and molecular analyses were performed on two siblings of consanguineous Pakistani origin, presenting with hyperchylomicronaemia, which revealed that the disorder resulted from lipoprotein lipase deficiency. Molecular analysis of the lipoprotein lipase gene has revealed a novel homozygous mutation, leucine to proline at amino acid residue 303, within the amino terminal domain ofthe protein.
Familial chylomicronaemia is a rare autosomal recessive genetic disorder occurring with a frequency of about 1 in 1 000 000 in most populations. The two major molecular defects responsible for this disorder are a deficiency of lipoprotein lipase (LPL) or its cofactor apolipoprotein C-II (apoC-II).
LPL is a key enzyme in the hydrolysis of triglycerides in plasma lipoproteins. LPL Case reports Patient 1 was an 11 year old girl who was born at term following a normal pregnancy and delivery to first cousin Pakistani parents. At the age of 7 months she was referred to a paediatrician by her general practitioner because of pallor and recurrent vomiting. In the outpatient clinic she appeared to be unwell and was admitted for further investigation. According to her parents she had vomited after her feeds of formula milk ever since birth. Her developmental progress had been normal. On admission she weighed 6.25 kg, was febrile, and looked pale. Her liver was palpable 1 cm below the costal margin and there was 3 cm splenomegaly. Investigations revealed lipaemic serum, haemoglobin of 57 g/l, and normal creatinine, electrolytes, and liver function tests. Further studies on fasting blood yielded the following results: triglyceride 19.2 mmol/l, cholesterol 5.9 mmol/l, LPL < 1 mmol/l/h (normal range 5-9), apoC-II present, a large increase in the VLDL fraction, post-heparin sample showed increased mobility of VLDL, serum iron < 1 gmol/l, haemoglobin electrophoresis normal.
A diagnosis of LPL deficiency was made and a low fat diet implemented. Iron deficiency was treated with an oral iron supplement. Subsequently, she has grown well, but despite good dietary compliance, she experiences recurrent bouts of abdominal pain and has required admission to hospital on 14 occasions, seven of these with pancreatitis.
A further child was born to the family two years later (patient 2). LPL is aligned to Leu 327 in pancreatic lipase and is conserved in human LPL and human and canine pancreatic lipase. This residue is within the amino terminal domain of LPL but does not seem to be involved directly in the catalytic site. Examination of the Leu 327 residue in human pancreatic lipase, using the graphics software RASMOL, shows that the conformation of this leucine is fully extended, and the side chain is packed into the molecule core. This conformation would not be possible with proline at this position, because proline is an imino acid, with a different torsion angle at its a carbon-nitrogen bond. Also, the proline nitrogen is unavailable to form hydrogen bonds with other residues within the protein. Hence, the Leu3O3Pro mutation would introduce some disturbance in the LPL structure. It is possible that proline at residue 303 could cause cis/trans disturbances such that the LPL protein would be unable to fold. It is also possible that the Leu3O3Pro mutant LPL does fold, but that the structure formed is thermally unstable or leads to an inactive enzyme. As the patients studied are actually deficient in LPL, it is probable that the Leu3O3Pro mutation disturbs the LPL folding pathway in such a way that, if the protein can fold, it is not a stable structure. Such a mutant LPL protein would be difficult to study functionally by expression in recombinant cells as similar structural instability problems would be encountered.
The GAG-4GAA silent mutation at codon 1 18 does not affect the amino acid sequence of LPL. However there may be an effect via codon usage from this sequence change, thus influencing the translational efficiency of LPL mRNA.
